Entry Point Capital, LLC Neogenomics Inc Transaction History
Entry Point Capital, LLC
- $246 Million
- Q3 2025
A detailed history of Entry Point Capital, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 23,176 shares of NEO stock, worth $239,639. This represents 0.07% of its overall portfolio holdings.
Number of Shares
23,176
Previous 35,490
34.7%
Holding current value
$239,639
Previous $259,000
31.27%
% of portfolio
0.07%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
290Shares Held
131MCall Options Held
1.3MPut Options Held
395K-
Black Rock Inc. New York, NY19.7MShares$203 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$144 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN9.93MShares$103 Million9.2% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD8.22MShares$85 Million2.48% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$61.8 Million0.02% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.3B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...